Clinical Trials Browser

Phase 1/2 × Frailty × 90 days × Clear all

NCT05968144 2026-01-27

ADRIAN

Phase 1/2 Active not recruiting

BreastGenitourinary

Frailty, Breast Neoplasms, Prostatic Neoplasms